Volume 17, Number 5—May 2011
Research
Travel-related Dengue Virus Infection, the Netherlands, 2006–2007
Table 2
Characteristics of travelers with serologic evidence of recent dengue virus infection from a cohort of 1,207 persons who traveled from the Netherlands to developing countries, October 1, 2006–September 30, 2007*
Traveler no.: age, y/sex | Country of birth | Destination country (region) | Previous times traveled to developing country | Travel-related signs and symptoms | Dengue-like illness | Vaccinated against yellow fever | IgM-ratio† | IgG-ratio† |
---|---|---|---|---|---|---|---|---|
1: 33/M | The Netherlands | Philippines (Asia) | 2–5 | Fever, myalgia, headache, retro-orbital pain, diarrhea | Yes | Never | NA | 17.65 |
2: 62/M | Germany | Indonesia (Asia) | 0 | Skin rash, diarrhea | No | Never | 51.79 | 38.9 |
3: 64/M | The Netherlands | Sri Lanka (Asia) | >10 | Fever, myalgia, arthralgia, head-ache, retro-orbital pain, diarrhea | Yes | In 1992 | NA | 28.3 |
4: 41/M | The Netherlands | Cambodia, Thailand, Malaysia, Philippines (Asia) | >10 | None | No | Never | NA | 46.27 |
5: 36/F | The Netherlands | Thailand, Singapore (Asia) | 6–10 | Diarrhea | No | Never | 3.34 | NA |
6: 37/F | The Netherlands | Indonesia (Asia) | 0 | Fever, myalgia, headache, retro-orbital pain, skin rash | Yes | Never | 48.66 | 142.25 |
7: 28/M | The Netherlands | Vietnam (Asia) | 2–5 | None | No | Never | 2.78 | NA |
8: 27/M | The Netherlands | India, Nepal (Asia) | 2–5 | Diarrhea | No | Never | 5.11 | NA |
9: 68/M | The Netherlands | Surinam (Latin America) | 1 | None | No | In 2000 | NA | 8.91 |
10: 26/F | The Netherlands | Argentina, Bolivia, Brazil, Chili, Uruguay (Latin America) | 0 | Fever, myalgia, arthralgia, headache, skin rash, diarrhea | Yes | For this trip | NA | 26.67 |
11: 23/F | The Netherlands | Surinam (Latin America) | 1 | Skin rash, diarrhea | No | For this trip | NA | 72.82 |
12: 54/F | The Netherlands | Gambia (Africa) | 2–5 | Fever, myalgia, arthralgia, head-ache, retro-orbital pain, diarrhea | Yes | For this trip | NA | 26.87 |
13: 27/M | The Netherlands | Mali, Burkina Faso (Africa) | 2–5 | Skin rash, diarrhea | No | In 2000 | 18.15 | NA |
14: 52/M | The Netherlands | Madagascar (Africa) | 6–10 | Diarrhea | No | In 1992 | 8.82 | NA |
*Ig, immunoglobulin; NA, ratio not available.
†Posttravel to pretravel. If the posttravel sample test results were negative for a type of anti-DENV, the pretravel serum sample was not tested for that type of antibody.